Related references
Note: Only part of the references are listed.The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells
Zhiyuan Hu et al.
CANCER CELL (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
1 Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
Dmitriy Zamarin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma
Soichiro Kakimoto et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Precise T cell recognition programs designed by transcriptionally linking multiple receptors
Jasper Z. Williams et al.
SCIENCE (2020)
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Michael-Antony Lisio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway
Isabelle Matte et al.
BMC CANCER (2019)
The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
Elisabetta Romeo et al.
CELLS (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
Allen W. Zhang et al.
CELL (2018)
MUC16 as a novel target for cancer therapy
Abhijit Aithal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
Haiying Qin et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
Charlotte S. Lo et al.
CLINICAL CANCER RESEARCH (2017)
T-cell target antigens across major gynecologic cancers
Alba Rodriguez-Garcia et al.
GYNECOLOGIC ONCOLOGY (2017)
Toil enables reproducible, open source, big biomedical data analyses
John Vivian et al.
NATURE BIOTECHNOLOGY (2017)
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
Shingo Inaguma et al.
ONCOTARGET (2017)
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
Takashi Eguchi et al.
ONCOTARGET (2017)
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
Liu Zhenjiang et al.
EBIOMEDICINE (2017)
Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning Platform
Kathryn M. Frietze et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
Kamila Kloudova et al.
ONCOTARGET (2016)
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity
De-Gang Song et al.
ONCOTARGET (2015)
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
M. Koebel et al.
BRITISH JOURNAL OF CANCER (2014)
Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect
Sven Golfier et al.
MOLECULAR CANCER THERAPEUTICS (2014)
OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain
Alessandro Bressan et al.
DISEASE MARKERS (2013)
Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy
E. Despierre et al.
GYNECOLOGIC ONCOLOGY (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo
Evripidis Lanitis et al.
CANCER IMMUNOLOGY RESEARCH (2013)
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Julie S. Nielsen et al.
CLINICAL CANCER RESEARCH (2012)
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma
Takahiro Einama et al.
PANCREAS (2011)
Novel Monoclonal Antibodies Against the Proximal (Carboxy-Terminal) Portions of MUC16
Thapi Dharma Rao et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
Stefania Bellone et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kimberly R. Kalli et al.
GYNECOLOGIC ONCOLOGY (2008)
Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: Antigens for multi-targeted antibody-guided therapy
Subhash C. Chauhan et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer
Keith L. Knutson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma
MJ Yen et al.
CLINICAL CANCER RESEARCH (2006)
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
N Parker et al.
ANALYTICAL BIOCHEMISTRY (2005)
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas
HF Frierson et al.
HUMAN PATHOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
